InvestorsHub Logo
Followers 3
Posts 192
Boards Moderated 0
Alias Born 10/25/2013

Re: Astavakra post# 14992

Tuesday, 07/01/2014 3:27:59 PM

Tuesday, July 01, 2014 3:27:59 PM

Post# of 694584
From Fierce Biotech:

The optimism around Prophage is welcome news for Agenus, which has endured peaks and valleys on Wall Street amid concerns over the efficacy of cancer vaccines on the whole. Clinical uncertainties for ImmunoCellular Therapeutics ($IMUC), Northwest Biotherapeutics ($NWBO) and Agenus partner GlaxoSmithKline ($GSK) have cast a pall over the field, and the commercial failure of Dendreon's ($DNDN) similar Provenge hasn't helped on the public perception front.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News